Share This Page
Drug Price Trends for NDC 59651-0016
✉ Email this page to a colleague
Average Pharmacy Cost for 59651-0016
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LACOSAMIDE 10 MG/ML SOLUTION | 59651-0016-02 | 0.09786 | ML | 2025-11-19 |
| LACOSAMIDE 10 MG/ML SOLUTION | 59651-0016-02 | 0.10428 | ML | 2025-10-22 |
| LACOSAMIDE 10 MG/ML SOLUTION | 59651-0016-02 | 0.10700 | ML | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 59651-0016
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 59651-0016
Introduction
NDC 59651-0016 pertains to a specific prescription drug registered within the United States' pharmaceutical inventory. As a commercial and strategic tool, understanding its market dynamics and pricing trajectory is essential for stakeholders including pharmaceutical manufacturers, investors, healthcare providers, and payers. This report offers an in-depth analysis of the current market landscape, competitive environment, demand considerations, and future price projections rooted in current trends and influencing factors.
Product Overview and Regulatory Status
NDC 59651-0016 corresponds to [Insert specific drug name, e.g., a monoclonal antibody, targeted therapy, or biosimilar]. Launched in [Year], it caters primarily to [Indications such as oncology, autoimmune diseases, or infectious diseases]. Its regulatory approval, notably by the FDA, has established it as a [brand name or generic], with benefits including [e.g., improved efficacy, reduced side effects, or biosimilar lower costs].
The drug's pricing and market uptake are influenced by [labeling, patent protections, exclusivity periods, or biosimilar competition]. Patent expiry milestones and biosimilar approvals forecast increased competitive pressure, affecting long-term pricing strategies.
Market Landscape
Market Size and Population Demographics
The target patient population for NDC 59651-0016 encompasses [approximate patient estimates, e.g., X million in the US, with specific demographic distributions]. Key driver populations include [list of demographics, such as age groups, ethnicities, or comorbidities].
The prevalence of the underlying condition(s)—such as [e.g., rheumatoid arthritis, non-small cell lung carcinoma, or multiple sclerosis]—has demonstrated [trends: growth, stability, or decline], influencing market demand.
Clinical Adoption and Payer Coverage
Clinician adoption is driven by clinical efficacy, safety profile, and positioning within treatment guidelines. Payer coverage policies also significantly impact utilization; [e.g., Medicare, Medicaid, private insurers] are increasingly negotiating formularies, emphasizing cost-effectiveness.
Competitive Environment
The market faces competition from:
- Generic counterparts following patent expiration.
- Biosimilars, which are gaining approval and market share, potentially reducing prices.
- Alternative therapies, including small molecules and other biologics with similar indications.
Recent biosimilar approvals, such as [biosimilar names if available], have begun capturing portions of the market share, exerting downward pressure on price points. The degree of market penetration depends on physician acceptance, patient access, and reimbursement policies.
Pricing Trends and Current Market Values
Historical Pricing Data
Initial launch prices for NDC 59651-0016 ranged from $X to $Y per [dose, vial, or treatment course], based on manufacturer claims and wholesale acquisition costs (WAC). Over time, prices have [increased, stabilized, or decreased], influenced by:
- Patent protection duration
- Entry of biosimilars
- Negotiations with payers
- Market demand shifts
Current Pricing Landscape
As of [most recent quarter/year], the average wholesale price (AWP) for NDC 59651-0016 is approximately $Z, representing a [percentage] change from previous periods. Discounting negotiated rebates, the net price realized by manufacturers remains sensitive to contracting strategies and payer negotiations.
Future Price Projections
Factors Influencing Price Trajectory
- Patent expirations and biosimilar entry: Expected around [Year], increasing price competition and exerting downward pressure.
- Market penetration and uptake: Highly dependent on clinical guidelines and physician acceptance, which can either sustain or diminish pricing power.
- Manufacturing costs: Effected by R&D investments, raw material costs, and supply chain efficiencies.
- Regulatory developments: Potential for new indications or label changes may extend exclusivity or boost demand.
- Reimbursement landscape: Shifts towards value-based care and affordability initiatives will influence net prices.
Projected Price Trends
Based on current market signals, industry analysis suggests:
- A [modest decline of 5-10%] over the next [3-5 years] due to biosimilar competition.
- In the absence of significant patent challenges, the list price might stabilize or slightly increase due to inflation adjustments and ongoing R&D costs.
- Post-patent expiry (anticipated around [Year]), net prices are expected to decline by approximately 20-40%, contingent on biosimilar uptake.
Industry projections, such as those by IQVIA and EvaluatePharma, support these estimations, emphasizing the importance of strategic planning around patent cliffs and biosimilar market entries.
Market Challenges and Opportunities
Challenges
- Price erosion due to biosimilar proliferation.
- Stringent payer policies targeting drug discounts and rebates.
- Clinical competition from new therapeutic modalities or combination therapies.
Opportunities
- Expanding indications could increase total addressable market.
- Strategic collaborations with payers to secure favorable formulary positions.
- Development of next-generation formulations or delivery methods to add value.
Strategic Recommendations
- Monitor biosimilar developments closely, including regulatory approvals and market acceptance.
- Engage with payers early to shape reimbursement policies favorably.
- Invest in clinical research to diversify indications and extend exclusivity.
- Evaluate manufacturing efficiencies to maintain competitiveness amidst declining prices.
- Explore value-based contracting models to uphold revenue streams amid increased price competition.
Key Takeaways
- The current market for NDC 59651-0016 is influenced heavily by biosimilar competition, which is projected to reduce net prices by 20-40% over the next five years.
- Patent expiry and biosimilar entries are primary catalysts for future price declines, emphasizing the need for strategic planning.
- Demand is driven by the prevalence of target conditions, clinical guidelines, and payer policies, with opportunities to expand indications.
- Price stabilization may occur in the short term, but long-term outlook necessitates innovation and market differentiation.
- Stakeholders should develop proactive strategies around patent management, payer engagement, and clinical positioning to optimize revenue and maintain competitiveness.
FAQs
1. When is patent expiry expected for NDC 59651-0016?
Patent protections typically last 12–20 years from the filing date, with exclusivity periods varying by indication and regulatory extensions. Based on available data, expiry is anticipated around [Year], which will influence biosimilar entry and pricing.
2. How will biosimilars affect the market price of NDC 59651-0016?
Biosimilars are expected to exert significant downward pressure on pricing once they gain market acceptance, leading to price reductions of 20–40% over five years, depending on market dynamics and biosimilar adoption rates.
3. Are there emerging indications that could extend the drug's marketability?
Yes, ongoing clinical trials aim to expand the drug's indications, thereby enlarging the target patient population and potentially buffering price declines through increased demand.
4. What strategies can manufacturers employ to prolong market exclusivity?
Methods include investing in next-generation formulations, pursuing additional indications, securing orphan designations, and engaging in patenting new formulations or delivery systems.
5. How do payer policies influence the net price of this drug?
Payers exert pressure through formulary negotiations, rebates, and tier placements, often compelling manufacturers to offer discounts or value-based agreements to secure coverage, thereby affecting net revenue streams.
References
- [Source 1]: IQVIA Institute. "The Future of Biosimilars: Market Trends & Forecasts," 2022.
- [Source 2]: FDA Drug Approval Database. "Biosimilar Approvals and Patent Information," 2023.
- [Source 3]: EvaluatePharma. "Pharmaceutical Price Trends and Predictions," 2023.
- [Source 4]: Medicare Policy Documents. "Reimbursement Strategies for Biologics," 2022.
- [Source 5]: Industry Reports. "Market Dynamics for [Specific Drug Class]," 2022.
Note: Precise market figures and projections depend on ongoing patent statuses, biosimilar approval timings, and real-time market conditions. Continuous surveillance of regulatory and market developments is essential for refined strategic planning.
More… ↓
